Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-024135
Filing Date
2021-05-05
Accepted
2021-05-05 16:35:24
Documents
87
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q srne-10q_20210331.htm   iXBRL 10-Q 2121265
2 EX-10.1 srne-ex101_76.htm EX-10.1 54623
3 EX-10.2 srne-ex102_212.htm EX-10.2 302011
4 EX-10.4 srne-ex104_129.htm EX-10.4 7414
5 EX-10.5 srne-ex105_187.htm EX-10.5 116277
6 EX-10.6 srne-ex106_188.htm EX-10.6 66417
7 EX-31.1 srne-ex311_12.htm EX-31.1 17154
8 EX-31.2 srne-ex312_8.htm EX-31.2 17004
9 EX-32.1 srne-ex321_6.htm EX-32.1 14931
  Complete submission text file 0001564590-21-024135.txt   9435533

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA srne-20210331.xsd EX-101.SCH 62036
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE srne-20210331_cal.xml EX-101.CAL 71507
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE srne-20210331_def.xml EX-101.DEF 241825
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE srne-20210331_lab.xml EX-101.LAB 470519
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE srne-20210331_pre.xml EX-101.PRE 398294
15 EXTRACTED XBRL INSTANCE DOCUMENT srne-10q_20210331_htm.xml XML 1687130
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

EIN.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36150 | Film No.: 21893973
SIC: 2836 Biological Products, (No Diagnostic Substances)